Authors:
Bruno, R
Regazzi, MB
Ciappina, V
Villani, P
Sacchi, P
Montagna, M
Panebianco, R
Filice, G
Citation: R. Bruno et al., Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV, CLIN PHARMA, 40(9), 2001, pp. 695-700
Authors:
Boni, C
Penna, A
Ogg, GS
Bertoletti, A
Pilli, M
Cavallo, C
Cavalli, A
Urbani, S
Boehme, R
Panebianco, R
Fiaccadori, F
Ferrari, C
Citation: C. Boni et al., Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy, HEPATOLOGY, 33(4), 2001, pp. 963-971
Authors:
Gartland, M
Gerstoft, J
Goebel, F
Clumeck, N
Cooper, DA
Gatell, J
Gazzard, B
Gerstoft, J
Goebel, F
Lange, J
Montaner, J
Reiss, P
Rozenbaum, W
Vella, S
Beveridge, A
Cooper, DA
Duncombe, C
Gold, J
Haberl, M
Clumeck, N
Luyts, D
Montaner, J
Rachlis, A
Marina, R
Gerstoft, J
Wandall, JH
Elbrond, B
Molina, JM
Pialloux, G
Rozenbaum, W
Beauvais, L
Goebel, FD
Staszewski, S
Bruns, I
Hug, M
Reiss, P
Lange, J
Frissen, PHJ
van der Ende, ME
Bosboom, M
Baas, C
Milazzo, F
Moroni, M
Panebianco, R
Clotet, B
Artigas, JMG
Gonzalez-Lahoz, J
Leal, M
Rodriguez-Lopo, C
Gandarias, B
Gazzard, B
Johnson, M
McKinley, S
Page, V
Watkins, K
Sandstrom, E
Belsey, E
Darbyshire, J
Chodakewitz, J
Isaacs, R
Jonas, L
Meibohm, A
Coughlan, M
Fiddian, P
Gartland, M
Harrigan, R
Larder, B
Maguire, M
Millard, J
Moore, S
Patel, K
Shortino, D
Tisdale, M
Vafidis, I
Yeo, J
Citation: M. Gartland et al., AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients, AIDS, 14(4), 2000, pp. 367-374